Industry Trends

Amcor Bemis Integration: What It Actually Means for Your Packaging Specs in 2025

Amcor Bemis Integration: What It Actually Means for Your Packaging Specs in 2025

I've been reviewing packaging deliverables for a mid-sized pharmaceutical company for six years now—roughly 340 SKUs annually across flexible films, pouches, and medical device packaging. When Amcor acquired Bemis Company back in 2019, honestly, I wasn't sure what to expect. Would specs change? Would our existing contracts hold? Would the Bemis healthcare packaging expertise we relied on get diluted into some generic global offering?

Now, five years post-acquisition, I have actual data. And the reality is more nuanced than the "bigger is better" or "acquisition ruins quality" narratives you'll find online.

The Comparison Framework: Pre-Acquisition Bemis vs. Post-Integration Amcor Bemis

Let me be clear about what I'm comparing here. This isn't Amcor vs. competitors like Sealed Air or Berry Global. This is: what changed for existing Bemis customers when the Amcor Bemis integration happened, and what should new customers expect in 2025?

I'm evaluating across four dimensions that matter to anyone in quality or procurement:

• Specification consistency
• Lead times and supply chain reliability
• Technical support access
• Pricing structure transparency

Specification Consistency: The Surprise Winner

Here's what I expected: post-acquisition standardization would water down Bemis's healthcare-specific capabilities. What actually happened was—well, different.

In our Q1 2024 quality audit, we compared barrier film specifications from our 2018 Bemis contracts against current Amcor Bemis deliverables. The oxygen transmission rate (OTR) specs we'd locked in? Still honored. Actually, the measurement consistency improved. In 2018, we saw OTR variance of ±8% batch-to-batch. In 2024, that dropped to ±4%.

I ran a blind test with our QC team: same barrier pouch design, one from a 2019 Bemis production run we'd stored, one from 2024 Amcor Bemis production. Seven of nine inspectors couldn't identify which was which. The two who could? They noted the newer sample had slightly better seal integrity—not worse.

"The 'acquisition always hurts quality' thinking comes from an era when acquisitions meant cost-cutting at any expense. That's changed—or at least, it has with this particular integration."

Should mention: this is for healthcare packaging specifically. I've heard different feedback from food packaging buyers, where the story seems more mixed.

Lead Times: Where It Gets Complicated

Okay, this dimension doesn't have a clean winner. Pre-acquisition Bemis had a 6-week standard lead time for custom healthcare pouches. Post-integration, that officially became 8 weeks.

But here's the thing—that 6-week number was aspirational. In 2018, we hit that target maybe 60% of the time. The other 40%, we were looking at 7-9 weeks with minimal communication about delays.

The current 8-week quote? We've hit it 85% of the time over the past 18 months. And when delays happen, we get notified at the 5-week mark instead of the day before expected delivery.

So: longer quoted lead time, but more reliable actual delivery. Whether that's better depends entirely on your planning cycle. For us, predictability matters more than optimistic promises. For JIT operations, that extra 2 weeks in the quote might be a dealbreaker.

The Global Network Factor

One genuine improvement: the Amcor global network has added backup production options. In March 2023, a equipment issue at one facility would've meant a 4-week delay under the old Bemis structure. Instead, production shifted to another Amcor facility and we lost 8 days. Still painful, but way less painful than a month.

That said—and I should add this—the shift required re-qualification testing on our end. Regulatory affairs wasn't thrilled. The packaging was functionally identical, but "different production site" triggered documentation requirements that cost us about $3,200 in testing fees.

Technical Support: Actually Better (With Caveats)

Pre-acquisition, Bemis technical support was excellent but stretched thin. Our dedicated rep knew our specs cold, but getting him on the phone sometimes took 48 hours.

Post-integration, we lost that specific rep. I won't pretend that didn't hurt—he'd been our contact for four years. The replacement took about six months to get fully up to speed on our requirements.

But now? Response time is consistently under 24 hours. The technical resources available are broader. When we needed barrier performance data for a new sterilization protocol in 2024, the Amcor Bemis team connected us with R&D specialists we never would've had access to as a mid-sized Bemis customer.

People think larger companies deliver worse service. Actually, larger companies can deliver better service because they have more specialists—the variable is whether they're organized to deploy them effectively. In this case, they are. Mostly.

Pricing: The Uncomfortable Truth

I went back and forth on whether to include specific numbers here. Ultimately decided transparency matters more than vendor diplomacy.

Our per-unit cost for a specific healthcare pouch configuration:

• 2018 (Bemis): $0.34/unit at 50,000 quantity
• 2024 (Amcor Bemis): $0.41/unit at 50,000 quantity

That's a 20.6% increase over six years. Sounds bad, right?

Except: Producer Price Index for plastics packaging increased about 18% over the same period (source: Bureau of Labor Statistics, Series PCU326110326110). Resin costs spiked in 2021-2022. Our increase is basically tracking inflation plus a small premium.

What did change: pricing structure transparency improved. The old Bemis quotes had about 8 line items. Current Amcor Bemis quotes break down to 14+ line items including tooling amortization, substrate costs, conversion costs, and logistics separately. More complex to review, but easier to identify where costs are actually coming from.

Volume Breaks Changed

This matters if you're a smaller buyer. Pre-acquisition Bemis volume breaks started at 25,000 units. Post-integration, first meaningful break is at 50,000 units. For our 50,000-unit annual order, no impact. For our colleagues at a smaller company ordering 30,000 units, they lost their pricing tier.

Bemis Sharps Container: A Different Product Line Entirely

Quick clarification because the search terms mix these up constantly: Bemis sharps containers—the medical waste disposal containers you see in clinics—are from Bemis Manufacturing Company, which is a completely separate business from what was Bemis Company, Inc. (the flexible packaging company Amcor acquired).

Bemis Manufacturing still operates independently. Makes toilet seats, sharps containers, other injection-molded products. Nothing to do with Amcor.

If you're here looking for sharps container specifications, you want bemismfg.com, not the Amcor Bemis flexible packaging operation. Totally different supply chain, different contacts, different everything. I've seen procurement teams confuse these, and it's a mess to untangle.

The Decision Framework: When Each Option Makes Sense

Based on 18 months of post-integration data, here's my honest assessment:

Amcor Bemis is probably right for you if:

• You need healthcare or pharmaceutical packaging with regulatory documentation
• Order volumes exceed 50,000 units annually
• Supply chain redundancy matters more than lowest possible price
• You value predictable lead times over aggressive timelines

You might want to look elsewhere if:

• Order volumes are under 30,000 units (volume breaks won't favor you)
• You need highly custom, small-batch flexible packaging
• Speed matters more than consistency—some regional specialists quote faster
• Your application doesn't require the barrier performance they've invested in

What's Actually Changed Since 2019

The fundamentals haven't changed, but the execution has transformed. Bemis's healthcare packaging expertise survived the acquisition—in our experience, it's actually been reinforced with better resources. The trade-off is higher minimum volumes and longer quoted lead times.

What was best practice in 2020—small regional vendors for flexibility, Bemis for specialized healthcare applications—still mostly applies in 2025. The Amcor Bemis option has just become more clearly positioned: they're optimized for medium-to-large scale healthcare and pharmaceutical packaging where consistency and documentation matter more than speed or cost.

For our quality team, that trade-off works. We rejected 12% of first deliveries in 2018 across all vendors. In 2024, Amcor Bemis deliverables hit a 4% rejection rate—our lowest of any flexible packaging supplier. That quality issue we had with a competitor cost us a $22,000 redo and delayed our product launch by three weeks. The premium for consistency? Worth it.

Your math might be different. Run the numbers for your specific situation.